CRISTALLI, Gloria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.690
EU - Europa 3.987
AS - Asia 2.567
Continente sconosciuto - Info sul continente non disponibili 45
SA - Sud America 42
AF - Africa 8
OC - Oceania 5
Totale 20.344
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.189
CN - Cina 1.973
DE - Germania 772
IT - Italia 735
SE - Svezia 527
UA - Ucraina 517
CA - Canada 494
GB - Regno Unito 443
SG - Singapore 333
FR - Francia 300
FI - Finlandia 258
PL - Polonia 192
TR - Turchia 167
IE - Irlanda 111
EU - Europa 45
CZ - Repubblica Ceca 34
BE - Belgio 33
BR - Brasile 29
IR - Iran 29
RO - Romania 14
VN - Vietnam 13
IN - India 12
ES - Italia 9
CL - Cile 7
NL - Olanda 7
AT - Austria 5
SK - Slovacchia (Repubblica Slovacca) 5
AR - Argentina 4
HK - Hong Kong 4
JP - Giappone 4
KR - Corea 4
RU - Federazione Russa 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
CH - Svizzera 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
DK - Danimarca 2
DZ - Algeria 2
GR - Grecia 2
GT - Guatemala 2
NP - Nepal 2
TN - Tunisia 2
VE - Venezuela 2
ZA - Sudafrica 2
BG - Bulgaria 1
BT - Bhutan 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 20.344
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.513
Fairfield 1.481
Jacksonville 1.351
Chandler 1.043
Houston 1.031
Ashburn 808
Wilmington 677
Seattle 658
Ann Arbor 641
Boardman 521
Nanjing 509
Cambridge 498
Toronto 330
Dearborn 216
San Mateo 207
Kraków 189
Singapore 189
Düsseldorf 187
Lawrence 169
Princeton 169
Columbus 162
Lachine 155
Nanchang 147
Beijing 145
Ogden 143
Istanbul 142
Dublin 111
Shenyang 89
Helsinki 82
Kunming 82
New York 82
Hebei 76
Tianjin 76
London 74
Guangzhou 73
Milan 71
San Diego 71
Shanghai 68
Jiaxing 57
Los Angeles 49
Venezia 47
Camerino 46
Jinan 43
Changsha 37
Ningbo 37
Chicago 35
Wuhan 35
Brussels 33
Hefei 28
Orange 28
Redwood City 28
Zhengzhou 28
Hangzhou 27
Falls Church 24
Verona 24
Brno 23
Detroit 23
Kocaeli 23
Philadelphia 23
Lanzhou 21
Norwalk 21
Taizhou 21
Venice 21
Auburn Hills 20
Munich 20
Washington 20
Leawood 19
Nürnberg 19
Bremen 18
Ardabil 17
Jinhua 16
Yiwu 14
Changchun 13
Perugia 13
Dong Ket 12
Shenzhen 12
Frankfurt am Main 11
Fuzhou 11
Indiana 10
Tappahannock 10
Augusta 8
Buffalo 8
Hanover 8
Simi Valley 8
Andover 7
Granada 7
Horia 7
Hounslow 7
Paris 7
Rome 7
Council Bluffs 6
Espoo 6
Kilburn 6
Monmouth Junction 6
Old Bridge 6
Walnut 6
Acton 5
Americana 5
Ascoli Piceno 5
Chengdu 5
Totale 15.403
Salva come PNG Salva come JPEG
Nome #
Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones 220
Adenine based acyclic-nucleotides as novel P2X3 receptor ligands 211
Human cytidine deaminase: understanding the catalytic mechanism 183
Neuropeptide S Receptor: recent updates on non-peptide antagonist discovery 177
Complex of dipeptidyl peptidase II with adenosine deaminase. 174
Composition and biological activity of essential oil of Achillea ligustica All. (Asteraceae) naturalized in central Italy: ideal candidate for anti-cariogenic formulations 172
Simultaneous Determination of Squalene, α-Tocopherol and β-Carotene in Table Olives by Solid Phase Extraction and High-Performance Liquid Chromatography with Diode Array Detection 172
Functional properties of subunit interactions in human cytidine deaminase 170
Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs 169
Purine and deazapurine nucleosides: synthetic approaches, molecular modeling and biological activity 168
2-Aralkynyl and 2-Heteroalkynyl derivatives of Adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists 167
Levels of polychlorinated biphenyls in fish and shellfish from the Adriatic Sea 166
Inhibition studies on membrane Adenosine Deaminase from human placenta 166
3'-Deoxyribofuranose derivatives of 1-deaza and 3-deaza adenosine and their activity as adenosine deaminase inhibitors 163
Synthesis and evaluation of hexitol nucleoside congeners as ambiguous nucleosides 160
“Third Joint Italian-German Purine Club Meeting - Purinergic Receptors: New Frontiers for Novel Therapies” 159
Determination of ink photoinitiators in packaged beverages by gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry 159
Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y(1) receptor antagonists and partial agonists 158
Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1 156
Comparative study of aroma profile and phenolic content of Montepulciano monovarietal red wines from the Marches and Abruzzo Regions of Italy using HS-SPME-GC-MS and HPLC-MS 156
Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family 156
9-ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities 156
Adenine and deazaadenine nucleoside and deoxynucleoside analogues: inhibition of viral replication of sheep MVV (in vitro model for HIV) and bovine BHV-1 155
2-Substituted N-ethylcarboxamidoadenosine derivatives as high affinity agonists at human A(3) adenosine receptors 154
2-Alkynyl derivatives of adenosine and adenosine-5'-N-ethyluronamide as selective agonists at A2 adenosine receptors 153
Adenosine deaminase: Functional implications and different classes of inhibitors 152
Evidence for the existence of a specific G protein-coupled receptor activated by guanosine 152
Optimization of espresso machine parameters through the analysis of coffee odorants by HS-SPME–GC/MS 151
Antiviral properties of deazaadenine nucleoside derivatives 151
Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17 150
Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles 150
Strong enhancement of vibrational relaxation by Watson-Crick base pairing 149
Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. 149
Synthesis and receptor affinity of polysubstituted adenosines 148
Molecular modeling studies on the human neuropeptide S receptor and its antagonists. 148
Molecular modeling study on potent and selective adenosine A3 receptor agonists. 148
Identification of alpha(1)-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens 147
The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors 147
Ring opening reactions: synthesis of AICAR analogs as potential antimetabolite agents 146
Functional residues at the active site of bovine brain adenosine deaminase. 146
Synthesis and evaluation of anti-HIV-1 and antitumor activity of 2',3'-didehydro-2',3'-dideoxy-3-deazaadenosine, 2',3'-dideoxy-3-deazaadenosine and some 2',3'-dideoxy-3-deazaadenosine 5'-dialkyl phosphates 145
CX3CL1-induced modulation at CA1 synapses reveals multiple mechanisms of EPSC modulation involving adenosine receptor subtypes. 145
Chemical and pharmacological profile of selective adenosine receptor agonists 144
GPCRs as therapeutic targets: a view on adenosine receptors structure and functions, and molecular modeling support 143
Glandular trichomes and essential oil composition of endemic Sideritis italica (Mill.) Greuter et Burdet from central Italy 143
Purine and 1-deazapurine ribonucleosides and deoxyribonucleosides: synthesis and biological activity 142
Synthesis and adenosine deaminase inhibitory activity of 3’-deoxy-1-deazaadenosines 142
Pharmacological postconditioning of the rabbit heart with non-selective, A1, A2A and A3 adenosine receptor agonists 142
Introduction of alkynyl chains on C-8 of adenosine led to very selective antagonists of the A(3) adenosine receptor 141
Unexpected synthesis of acyclic adenine nucleosides 141
Diazepinone nucleosides as inhibitors of cytidine deaminase 141
Kinetic and structural analysis of the inhibition of adenosine deaminase by acetaminophen 140
Purification of human cytidine deaminase : Molecular and enzymatic characterization and inhibition by synthetic pyrimidine analogs 140
Potent and selective ligands for adenosine binding sites 140
Coupling of 2,6-disubstituted purines to ribose-modified sugars 139
A preliminary matrix-assisted laser desorption/ionization time-of-flight approach for the characterization of Italian lentil varieties 139
Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: Insight into the receptor activation switch 139
Adenosine receptor modeling: what does the A2A crystal structure tell us? 138
Volatile components in whole and different plant parts of Bastard Balm (Melittis melissophyllum L, Lamiaceae) collected in central Italy and Slovakia 137
8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A(2A) and A(2B) receptors ligands 136
A2A adenosine receptor antagonists 135
New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile 134
2-Alkynyl derivatives of Adenosine-5'-N-ethyluronamide (NECA): selective A2 adenosine receptor agonists with potent inhibitory activity on Platelet aggregation 134
A2A adenosine receptor antagonists 134
Coupling of 2,6-dichloropurine and 2,6-dichlorodeazapurines with ribose and ribose modified sugars 133
Structure-activity relationships of adenosine deaminase inhibitors 133
Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas 132
N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists of the A1 adenosine receptor 132
Chemical differences in volatiles between Melittis melissophyllum L subsp melissophyllum and subsp albida (Guss) PW Ball (Lamiaceae) determined by solid phase microextraction (SPME) coupled to GC/FID and GC/MS 132
Synthesis, structure-affinity relationships and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists 132
Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists. Synthesis, structure-affinity relationships and molecular modeling studies 131
A(2A) Adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists 130
Human cytidine deaminase: a three dimensional homology model of a tetrameric metallo-enzyme inferred from the crystal structure of distantly related dimeric homologue 130
Synthesis and adenosine receptor affinity and potency of 8-alkynyl derivatives of adenosine 130
Synthesis and stability studies of 2 ',3 ',5 '-tri-O-acetyl-2-amino(-N-6-cyclopentyl)-1-deazaadenosines 129
A(2A) adenosine receptor agonists reduce both high-palatability and low-palatability food intake in female rats 129
Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists 129
Synthesis and antitumor activity of 2-ß-D-ribofuranosyloxazole-4-carboxamide (oxazofurin). 129
null 128
Biological activity of 1-deazapurine nucleosides: role of deoxycytidine kinase 128
Modulation of apoptosis in human lymphocytes by adenosine analogues 127
Evidence for the functional expression and pharmacological characterization of adenine receptors in native cells and tissues 127
Photoinactivation studies on adenosine deaminase 125
Adenosine A(2A) receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease 124
European medicinal chemistry education: the transformational accomplishments and challenges 124
Characterization of potent ligands at human recombinant adenosine receptors 123
Effects of 5 '-phosphate derivatives of 2-hexynyl adenosine and 2-phenylethynyl adenosine on responses of human platelets mediated by P2Y receptors 123
Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists 122
Well water in central Italy: Analysis of herbicide residues as potential pollutants of untreated crops 121
2- And 8- alkynyladenosines: conformational studies and docking to human adenosine A(3) receptor can explain their different biological behavior 120
Synthesis of 1,7-dideazapurine ribonucleosides and deoxyribonucleosides 119
Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase 118
Human adenosine A3 receptor as selective target of new 2-aralkynyl-N6-methyl-MECA derivatives 118
Platelet aggregation inhibitory activity of selective A2 adenosine receptor agonists. 117
2-substituted 5 '-N-methylcarboxamidoadenosine (MECA) derivatives as A(3) adenosine receptor ligands 116
P2 receptor antagonists prevent synaptic failure and extracellular signal-regulated kinase ½ activation induced by oxygen and glucose deprivation in rat CA1 hippocampus in vitro 116
Further studies on intersubunit interactions in human cytidine deaminase 115
Synthesis of new nucleosides by coupling of chloropurines with 2- and 3-deoxy derivatives of N-methyl-D-ribofuranuronamide 113
Cytidine dEaminase from human placenta 113
Synthesis of 3-deazaclitocine [2-amino-3-nitro-4-(beta-D-ribofuranosylamino)pyridine] as cytotoxic agent 112
Totale 14.268
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.646
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.646
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.306 0 0 0 0 247 413 370 434 267 266 100 209
2020/20212.716 97 228 149 206 133 215 403 31 254 75 582 343
2021/20221.875 188 457 33 95 126 116 67 140 127 206 106 214
2022/20232.475 225 87 72 422 314 375 3 160 489 122 154 52
2023/20241.542 260 92 90 51 73 168 43 46 169 36 16 498
2024/20251.089 150 147 448 239 105 0 0 0 0 0 0 0
Totale 20.565